Related references
Note: Only part of the references are listed.Development of therapeutic antibodies for the treatment of diseases
Zeng Wang et al.
MOLECULAR BIOMEDICINE (2022)
A global analysis of the reconstitution of PTEN function by translational readthrough of PTEN pathogenic premature termination codons
Sandra Luna et al.
HUMAN MUTATION (2021)
PTENε suppresses tumor metastasis through regulation of filopodia formation
Qiaoling Zhang et al.
EMBO JOURNAL (2021)
PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer
Yizhe Sun et al.
NATURE COMMUNICATIONS (2021)
The Clinical Spectrum of PTEN Mutations
Lamis Yehia et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives
Hilal Ahmed Parray et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Development of therapeutic antibodies for the treatment of diseases
Ruei-Min Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Unique properties of PTEN-L contribute to neuroprotection in response to ischemic-like stress
Magdalena C. E. Jochner et al.
SCIENTIFIC REPORTS (2019)
PTENα promotes neutrophil chemotaxis through regulation of cell deformability
Yunqiao Li et al.
BLOOD (2019)
Precise Immunodetection of PTEN Protein in Human Neoplasia
Rafael Pulido et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation
Shao-Ming Shen et al.
NATURE CELL BIOLOGY (2019)
Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function
Teresa Fernandez-Acero et al.
CELLS (2019)
Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology
Janire Mingo et al.
NPJ PRECISION ONCOLOGY (2019)
The pharmacology and therapeutic applications of monoclonal antibodies
Maria Sofia Castelli et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself
Ines Breuksch et al.
CELL COMMUNICATION AND SIGNALING (2018)
A pathogenic role for germline PTEN variants which accumulate into the nucleus
Janire Mingo et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
The functions and regulation of the PTEN tumour suppressor: new modes and prospects
Yu-Ru Lee et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription
Hui Liang et al.
NATURE COMMUNICATIONS (2017)
PTEN proteoforms in biology and disease
Prerna Malaney et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
One-Tube-Only Standardized Site-Directed Mutagenesis: An Alternative Approach to Generate Amino Acid Substitution Collections
Janire Mingo et al.
PLOS ONE (2016)
Inherited PTEN mutations and the prediction of phenotype
Nicholas R. Leslie et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
PTEN: A yin-yang master regulator protein in health and disease
Rafael Pulido
METHODS (2015)
Catalysis by the Tumor-Suppressor Enzymes PTEN and PTEN-L
Sean B. Johnston et al.
PLOS ONE (2015)
PTEN
Carolyn A. Worby et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83 (2014)
PTENα, a PTEN Isoform Translated through Alternative Initiation, Regulates Mitochondrial Function and Energy Metabolism
Hui Liang et al.
CELL METABOLISM (2014)
A Unified Nomenclature and Amino Acid Numbering for Human PTEN
Rafael Pulido et al.
SCIENCE SIGNALING (2014)
The PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapy
Prerna Malaney et al.
MOLECULAR BIOSYSTEMS (2013)
A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival
Benjamin D. Hopkins et al.
SCIENCE (2013)
A functional network of the tumor suppressors APC, hDlg, and PTEN, that relies on recognition of specific PDZ-domains
Natalia S. Sotelo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN
Amparo Andres-Pons et al.
CANCER RESEARCH (2007)
Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer
S Agrawal et al.
HUMAN MOLECULAR GENETICS (2006)
Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN
S Agrawal et al.
HUMAN MOLECULAR GENETICS (2005)
Functional definition of relevant epitopes on the tumor suppressor PTEN protein
A Andrés-Pons et al.
CANCER LETTERS (2005)
Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3 - Implications for the control of protein stability and PTEN-protein interactions
J Torres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A novel loss-of-function mutation (N48K) in the PTEN gene in a Spanish patient with Cowden disease
A Vega et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues
J Torres et al.
EUROPEAN JOURNAL OF CANCER (2001)
Alternative splicing of the human PTEN/MMAC1/TEP1 gene
RM Sharrard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2000)
Share Paper
